|
Market Closed -
Bombay S.E.
06:02:26 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 6,098.65 INR | +0.36% |
|
+2.97% | -32.31% |
| 10-16 | AstraZeneca Pharma India Limited Opens New Corporate Office in Mumbai | CI |
| 09-18 | Astrazeneca Pharma India Limited Receives Penalty Order from Registrar of Companies, Bengaluru, Karnataka | CI |
| Market Cap | 152B 1.61B 1.43B 1.33B 1.2B 2.26B 2.29B 15.92B 6.25B 79.86B 6.04B 5.91B 254B | P/E 2025 |
186x | P/E 2026 | 103x |
|---|---|---|---|---|---|
| Enterprise Value | 149B 1.57B 1.4B 1.3B 1.18B 2.21B 2.24B 15.57B 6.11B 78.08B 5.91B 5.78B 249B | EV / Sales 2025 |
12.2x | EV / Sales 2026 | 8.38x |
| Free-Float |
18.52% | Yield 2025 |
0.37% | Yield 2026 | 0.46% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ASTRAZEN | Delayed | |
NSE India S.E.
| ASTRAZEN | Delayed |
| 1 day | +0.36% | ||
| 1 week | +2.97% | ||
| Current month | -1.46% | ||
| 1 month | -9.14% | ||
| 3 months | -24.08% | ||
| 6 months | -27.77% | ||
| Current year | -32.31% |
| 1 week | 5,850 |  | 6,130.85 |
| 1 month | 5,660 | | 6,730 |
| Current year | 5,660 | | 9,219.25 |
| 1 year | 5,660 | | 9,850 |
| 3 years | 4,050.15 | | 10,653.05 |
| 5 years | 2,437.75 | | 10,653.05 |
| 10 years | 882.55 | | 10,653.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2025-06-30 | |
Harish Dash
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-02 |
| Compliance Officer | - | 2026-02-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 67 | 2016-12-01 |
| Chairman | 52 | 2024-09-29 | |
Hooi-Bien Chuah
BRD | Director/Board Member | - | 2023-11-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | +2.97% | -34.43% | +32.87% | 1.61B | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| -0.97% | +1.95% | +38.00% | +62.96% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.83% | +1.53% | +21.90% | +51.27% | 292B | |
| +0.24% | -0.47% | +0.78% | +25.13% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | +0.28% | +3.12% | +28.30% | +65.34% | 398.96B | |
| Weighted average by Cap. | +0.61% | +3.73% | +40.67% | +79.65% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 17.16B 182M 162M 150M 136M 256M 259M 1.8B 706M 9.02B 682M 668M 28.75B | 22.76B 241M 215M 199M 180M 339M 343M 2.39B 936M 11.96B 905M 886M 38.12B |
| Net income | 1.16B 12.26M 10.93M 10.12M 9.16M 17.25M 17.46M 121M 47.6M 608M 46.01M 45.05M 1.94B | 1.88B 19.87M 17.71M 16.39M 14.84M 27.95M 28.28M 197M 77.13M 986M 74.54M 72.99M 3.14B |
| Net Debt | -5B -53.03M -47.25M -43.75M -39.59M -74.59M -75.48M -525M -206M -2.63B -199M -195M -8.38B | -3.37B -35.72M -31.83M -29.47M -26.67M -50.24M -50.84M -353M -139M -1.77B -134M -131M -5.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-22 | ₹6,098.65 | +0.36% | 199 |
| 26-10-21 | ₹6,076.90 | +0.56% | 1,073 |
| 26-10-19 | ₹6,043.30 | +1.29% | 177 |
| 26-10-16 | ₹5,966.05 | +0.73% | 117 |
| 26-10-15 | ₹5,922.60 | -0.35% | 292 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ASTRAZEN Stock
Select your edition
All financial news and data tailored to specific country editions
